Literature DB >> 35774900

Chronic Synthetic Marijuana Use: A Case of First-Onset Seizures as a Withdrawal Symptom.

Amber N Edinoff1, Prithvi Doppalapudi1, Juliana M Fort1.   

Abstract

A 44-year-old male with no known past medical history but a known history of daily synthetic marijuana use presented to the emergency department after two witnessed seizures. The patient was admitted to the neurology service, where he was worked up with an MRI with epilepsy protocol and an EEG. During admission, the patient was admitted to daily synthetic marijuana use. He did note that he had started to decrease the amount of mojo he used daily in an attempt to stop. His last use was at 9 am the day of his admission. He was trying to decrease his use; his girlfriend of difficulty word-finding noted periods. Synthetic marijuana (SM) or "mojo" use has been increasing in the past decade for two reasons; It is considered an herbal product and has been legal. A withdrawal syndrome of SM use has been characterized chiefly as tachycardia, irritation, anxiety, and mood swings. These withdrawal symptoms are usually seen with chronic use. Some early results in the literature also show that SM use can lead to functional and structural neuronal changes. This manuscript discusses a case of a first on-set seizure as a possible withdrawal symptom in chronic SM use.

Entities:  

Keywords:  Mojo; Spice; Synthetic Marijuana; Withdrawal; first onset seizures; seizures

Year:  2022        PMID: 35774900      PMCID: PMC9239357          DOI: 10.52965/001c.34617

Source DB:  PubMed          Journal:  Health Psychol Res        ISSN: 2420-8124


  11 in total

1.  Convulsions associated with the use of a synthetic cannabinoid product.

Authors:  Aaron B Schneir; Todd Baumbacher
Journal:  J Med Toxicol       Date:  2012-03

2.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 3.  Cannabis as a cause of death: A review.

Authors:  Olaf H Drummer; Dimitri Gerostamoulos; Noel W Woodford
Journal:  Forensic Sci Int       Date:  2019-03-14       Impact factor: 2.395

4.  Internet highs--seizures after consumption of synthetic cannabinoids purchased online.

Authors:  Babak Tofighi; Joshua D Lee
Journal:  J Addict Med       Date:  2012-09       Impact factor: 3.702

5.  Abnormal white matter integrity in synthetic cannabinoid users.

Authors:  Nabi Zorlu; Maria Angelique Di Biase; Çiğdem Çolak Kalaycı; Andrew Zalesky; Başak Bağcı; Nihan Oğuz; Fazıl Gelal; Lütfullah Beşiroğlu; Şeref Gülseren; Aybala Sarıçiçek; Emre Bora; Christos Pantelis
Journal:  Eur Neuropsychopharmacol       Date:  2016-09-09       Impact factor: 4.600

6.  The synthetic cannabinoid withdrawal syndrome.

Authors:  Nicholas Nacca; Deepak Vatti; Ross Sullivan; Payal Sud; Mark Su; Jeanna Marraffa
Journal:  J Addict Med       Date:  2013 Jul-Aug       Impact factor: 3.702

7.  The secret "spice": an undetectable toxic cause of seizure.

Authors:  Adam de Havenon; Brian Chin; Karen C Thomas; Pegah Afra
Journal:  Neurohospitalist       Date:  2011-10

8.  Historical and Current Perspectives of Synthetic Marijuana: Critical Review.

Authors:  Lisa Vera; Kunsook Bernstein; Seatbyul Lee
Journal:  J Addict Nurs       Date:  2020 Apr/Jun       Impact factor: 1.476

9.  Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ9-Tetrahydrocannabinol.

Authors:  Chris S Breivogel; Jacob R Wells; Amreen Jonas; Artik H Mistry; Morgan L Gravley; Rajul M Patel; Brianna E Whithorn; Bonnie M Brenseke
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 10.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.

Authors:  Koby Cohen; Aviv M Weinstein
Journal:  Front Public Health       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.